SpectrumX is a UK-based pharmaceutical manufacturer operating an MHRA-licensed facility for the production of high-quality liquid medicines. The company specialises in unlicensed medicines and provides end-to-end manufacturing services, including formulation development, process validation, and global distribution. Operating under GMP and GDP frameworks, SpectrumX ensures full traceability, regulatory compliance, and scalable production to meet the needs of international healthcare markets.